Response Genetics, Inc. Announces Contract With Blue Shield of California

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

LOS ANGELES, May 16, 2013 (GLOBE NEWSWIRE) -- Response Genetics, Inc. (Nasdaq:RGDX), a company focused on the development and sale of molecular diagnostic tests that help determine a patient's response to cancer therapy, today announced that it has entered into an agreement with health insurer Blue Shield of California to join all of Blue Shield of California's provider networks.

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC